Shelly L. Lorey

1.5k total citations
24 papers, 866 citations indexed

About

Shelly L. Lorey is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Shelly L. Lorey has authored 24 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Virology. Recurrent topics in Shelly L. Lorey's work include Immune Cell Function and Interaction (8 papers), HIV Research and Treatment (7 papers) and Cancer-related gene regulation (7 papers). Shelly L. Lorey is often cited by papers focused on Immune Cell Function and Interaction (8 papers), HIV Research and Treatment (7 papers) and Cancer-related gene regulation (7 papers). Shelly L. Lorey collaborates with scholars based in United States, Germany and France. Shelly L. Lorey's co-authors include William P. Tansey, April M. Weissmiller, Gregory C. Howard, Lance R. Thomas, Stephen W. Fesik, Christine M. Eischen, Spyros A. Kalams, Qi Liu, Louise Barnett and Brian C. Grieb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Shelly L. Lorey

24 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shelly L. Lorey United States 17 573 247 164 138 66 24 866
Nikolas Herold Sweden 14 374 0.7× 120 0.5× 138 0.8× 173 1.3× 124 1.9× 34 765
Giovanni Fagà Italy 11 594 1.0× 113 0.5× 267 1.6× 56 0.4× 105 1.6× 16 876
Martha R. Neagu United States 10 396 0.7× 239 1.0× 110 0.7× 162 1.2× 53 0.8× 18 772
Jason M. Link United States 15 377 0.7× 353 1.4× 117 0.7× 50 0.4× 57 0.9× 32 791
Emil H. Palacios United States 7 319 0.6× 659 2.7× 224 1.4× 147 1.1× 32 0.5× 8 994
Carl‐Magnus Högerkorp Sweden 11 264 0.5× 309 1.3× 105 0.6× 102 0.7× 33 0.5× 16 662
Sumayah Jamal United States 10 329 0.6× 199 0.8× 161 1.0× 150 1.1× 47 0.7× 15 659
Haewon Sohn United States 16 246 0.4× 753 3.0× 125 0.8× 38 0.3× 67 1.0× 25 1.1k
Brenda Brankin United Kingdom 14 229 0.4× 88 0.4× 74 0.5× 50 0.4× 47 0.7× 24 569
Stéphanie Boireau France 13 867 1.5× 60 0.2× 94 0.6× 61 0.4× 105 1.6× 22 1.0k

Countries citing papers authored by Shelly L. Lorey

Since Specialization
Citations

This map shows the geographic impact of Shelly L. Lorey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelly L. Lorey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelly L. Lorey more than expected).

Fields of papers citing papers by Shelly L. Lorey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelly L. Lorey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelly L. Lorey. The network helps show where Shelly L. Lorey may publish in the future.

Co-authorship network of co-authors of Shelly L. Lorey

This figure shows the co-authorship network connecting the top 25 collaborators of Shelly L. Lorey. A scholar is included among the top collaborators of Shelly L. Lorey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelly L. Lorey. Shelly L. Lorey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyer, Christian T., Jing Wang, Brian C. Grieb, et al.. (2024). Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies. Proceedings of the National Academy of Sciences. 121(35). e2408889121–e2408889121. 4 indexed citations
2.
Howard, Gregory C., Jing Wang, Kristie L. Rose, et al.. (2023). Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition. eLife. 12. 9 indexed citations
3.
Wang, Jing, Lance R. Thomas, Brittany K. Matlock, et al.. (2022). WIN site inhibition disrupts a subset of WDR5 function. Scientific Reports. 12(1). 1848–1848. 16 indexed citations
4.
Guarnaccia, Alissa D., Kristie L. Rose, Jing Wang, et al.. (2021). Impact of WIN site inhibitor on the WDR5 interactome. Cell Reports. 34(3). 108636–108636. 36 indexed citations
5.
Wang, Jing, Clare M. Adams, Gregory C. Howard, et al.. (2021). MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1. eLife. 10. 58 indexed citations
6.
Wang, Jing, Alissa D. Guarnaccia, David L. Elion, et al.. (2021). Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler. Oncogene. 40(20). 3593–3609. 15 indexed citations
7.
Weissmiller, April M., Jing Wang, Shelly L. Lorey, et al.. (2019). Inhibition of MYC by the SMARCB1 tumor suppressor. Nature Communications. 10(1). 54 indexed citations
8.
Thomas, Lance R., Clare M. Adams, Jing Wang, et al.. (2019). Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance. Proceedings of the National Academy of Sciences. 116(50). 25260–25268. 77 indexed citations
9.
Thomas, Lance R., April M. Weissmiller, Brian C. Grieb, et al.. (2015). Interaction of MYC with host cell factor-1 is mediated by the evolutionarily conserved Myc box IV motif. Oncogene. 35(27). 3613–3618. 32 indexed citations
10.
Thomas, Lance R., Qingguo Wang, Brian C. Grieb, et al.. (2015). Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC. Molecular Cell. 58(3). 440–452. 215 indexed citations
11.
Chakraborty, Abhishek A., Claudio Scuoppo, Swati Dey, et al.. (2014). A common functional consequence of tumor-derived mutations within c-MYC. Oncogene. 34(18). 2406–2409. 22 indexed citations
12.
Zern, Emily K., et al.. (2013). B Cell Responses to HIV Antigen Are a Potent Correlate of Viremia in HIV-1 Infection and Improve with PD-1 Blockade. PLoS ONE. 8(12). e84185–e84185. 28 indexed citations
13.
Smith, Rita M., Jie Wei, Louise Barnett, et al.. (2012). Antiretroviral Therapy Reduces the Magnitude and T Cell Receptor Repertoire Diversity of HIV-Specific T Cell Responses without Changing T Cell Clonotype Dominance. Journal of Virology. 86(8). 4213–4221. 30 indexed citations
14.
Meyer‐Olson, Dirk, Brenna C. Simons, Rita M. Smith, et al.. (2010). Clonal expansion and TCR-independent differentiation shape the HIV-specific CD8+ effector-memory T-cell repertoire in vivo. Blood. 116(3). 396–405. 25 indexed citations
15.
16.
Simons, Brenna C., Scott E. VanCompernolle, Rita M. Smith, et al.. (2008). Despite Biased TRBV Gene Usage against a Dominant HLA B57-Restricted Epitope, TCR Diversity Can Provide Recognition of Circulating Epitope Variants . The Journal of Immunology. 181(7). 5137–5146. 28 indexed citations
17.
Lorey, Shelly L., Louise Barnett, Kirsten Haman, et al.. (2008). Enhancement of Human Immunodeficiency Virus (HIV)-Specific CD8+T Cells in Cerebrospinal Fluid Compared to Those in Blood among Antiretroviral Therapy-Naive HIV-Positive Subjects. Journal of Virology. 82(21). 10418–10428. 26 indexed citations
18.
Meyer‐Olson, Dirk, Kristin O’Sullivan, Brenna C. Simons, et al.. (2005). Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire. Blood. 107(6). 2373–2383. 45 indexed citations
19.
Lorey, Shelly L., et al.. (2004). Constitutive expression of Interleukin-18 and Interleukin-18 receptor mRNA in tumour derived human B-cell lines. Clinical & Experimental Immunology. 136(3). 456–462. 17 indexed citations
20.
Lorey, Shelly L., et al.. (2001). Autocrine Role of Macrophage Inflammatory Protein-1 β in Human T-Cell Lymphotropic Virus Type-I tax-Transfected Jurkat T-Cells. Biochemical and Biophysical Research Communications. 287(4). 910–913. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nikolas Herold Breakdown of academic impact, for papers by Giovanni Fagà Breakdown of academic impact, for papers by Martha R. Neagu Breakdown of academic impact, for papers by Jason M. Link Breakdown of academic impact, for papers by Emil H. Palacios Breakdown of academic impact, for papers by Carl‐Magnus Högerkorp Breakdown of academic impact, for papers by Sumayah Jamal Breakdown of academic impact, for papers by Haewon Sohn Breakdown of academic impact, for papers by Brenda Brankin Breakdown of academic impact, for papers by Stéphanie Boireau
Rankless by CCL
2026